FDA Risk Evaluation and Mitigation Strategies (REMS) : description and effect on generic drug development /

Bibliographic Details
Main Author:	Dabrowska, Agata (Author)
Format:	Government Document Database
Language:	English
Published:	[Washington, D.C.] : Congressional Research Service, 2018-
Edition:	[Library of Congress public edition].
Series:	CRS report ; R44810.
Subjects:	United States. > Food and Drug Administration. Generic drugs. Pharmaceutical industry > United States. Pharmaceutical industry > Materials management > United States.
Online Access:	https://purl.fdlp.gov/GPO/gpo114373

Description
Item Description:	The CRS report home page provides access to all versions published since 2018 in accordance with P.L. 115-141.
Physical Description:	1 online resource.
Publication Frequency:	Updated irregularly
Bibliography:	Report includes bibliographical references.